Correction

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies (vol 33, pg 581, 2018)

Journal

CANCER CELL
Volume 34, Issue 4, Pages 690-690

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2018.09.008

Keywords

-

Funding

  1. Bristol-Myers Squibb
  2. Merck
  3. Genentech
  4. Medimmune

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available